|
Wavelength (nm)a |
Maximum emission ratio changeb |
|
| Analyte or process |
Donor and acceptorc |
ΔFRETd |
Donor excitation |
Donor emission |
Acceptor emission |
References |
| Depolarization |
Coumarin-phosphatidylethanolamine; bis(thio barbiturate)trimethineoxonol |
↓ |
414 |
450 |
560 |
1.8/(100 mV) |
Gonzalez and Tsien (1997) |
| cAMP |
PKA catalytic subunit-FITC; PKA regulatory subunit-TROSue |
↓ |
495 |
520 |
580 |
1.6-2.2 |
Adams et al. (1991, 1993) |
| Trypsin |
BFP-(trypsin-sensitive linker)-GFP |
↓ |
380 |
445 |
507 |
4.6 |
Heim and Tsien (1996) |
| Factor Xa |
BFP-(factor Xa-sensitive linker)-GFP
|
↓ |
385 |
450 |
505 |
1.9 |
Mitra et al. (1996) |
| Caspase-3 |
BFP-(caspase-3-sensitive linker)-GFP |
↓ |
380 |
440 |
511 |
? |
Xu et al. (1998) |
| Ca2+-CaM
|
GFP-CBSM-BFP
|
↓ |
380 |
448 |
505 |
5.7 |
Romoser et al. (1997) |
| Ca2+ |
GFP-CBSM-BFP-CaMCN
|
↓ |
380 |
440 |
505 |
1.67 |
Persechini et al. (1997) |
| Ca2+ |
ECFP-CaM-M13-EYFP |
↑ |
433 |
476 |
527 |
2.1 |
Miyawaki et al. (1997, 1999) |
| Ca2+ |
ECFP-CaM; M13-EYFP |
↑ |
433 |
476 |
527 |
4 |
Miyawaki et al. (1997, 1999) |
| β-Lactamase expression |
Coumarin-cephalosporin-fluorescein (CCF2) |
↓ |
409 |
447 |
520 |
70 |
Zlokarnik et al. (1998) |
|
| aDonor excitation wavelength, donor emission wavelength, and acceptor emission wavelength, all in nanometers. Small differences
(up to 8 nm) in the wavelengths cited by different laboratories for BFP and GFPs are probably not significant.
|
| bMaximum factor by which emission ratio changes from zero to saturating levels of the analyte or process, except for depolarization
of 100 mV amplitude.
|
| cHyphens indicate covalent conjugation or fusion. Interacting donor and acceptor molecules are separated by semicolons.
|
| dFRET indicates whether the efficiency of fluorescence resonance energy transfer is increased (↑) or decreased (↓) by the analyte
or process.
|
| eTetramethylrhodamine N-hydroxysuccinimide.
|